HomeCOLL • NASDAQ
add
Collegium Pharmaceutical Inc
Previous close
$30.41
Day range
$29.80 - $30.76
Year range
$25.16 - $42.29
Market cap
966.22M USD
Avg Volume
404.21K
P/E ratio
14.98
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 159.30M | 16.53% |
Operating expense | 82.87M | 15.72% |
Net income | 9.34M | -54.76% |
Net profit margin | 5.86 | -61.17% |
Earnings per share | 1.61 | 20.15% |
EBITDA | 97.77M | 18.71% |
Effective tax rate | 40.08% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 144.96M | -52.41% |
Total assets | 1.64B | 38.86% |
Total liabilities | 1.40B | 40.27% |
Total equity | 234.28M | — |
Shares outstanding | 32.25M | — |
Price to book | 4.18 | — |
Return on assets | 10.42% | — |
Return on capital | 14.86% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 9.34M | -54.76% |
Cash from operations | -9.00M | -112.16% |
Cash from investing | -248.96M | -6,413.95% |
Cash from financing | 149.03M | 256.19% |
Net change in cash | -108.93M | -331.99% |
Free cash flow | 129.49M | 83.98% |
About
Founded
2002
Website
Employees
197
